학제간연구 | Interdisciplinary Studies in Gambling | 跨学科研究
- date : 2015-05-20 01:10|hit : 1993
-
- Review] The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis
-
DocNo of ILP: 20
Doc. Type: Review
Title: The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis
Authors: Sagoe, D; Molde, H; Andreassen, CS; Torsheim, T; Pallesen, S
Full Name of Authors: Sagoe, Dominic; Molde, Helge; Andreassen, Cecilie S.; Torsheim, Torbjorn; Pallesen, Stale
Keywords by Author: Steroids; Prevalence; Epidemiology; Meta-analysis; Regression; Systematic review
Keywords Plus: HIGH-SCHOOL-STUDENTS; DRUG-USE; RISK-FACTORS; BODY-IMAGE; UNITED-STATES; SUBSTANCE USE; PHYSICAL-EDUCATION; ENHANCING SUBSTANCES; SPORTS PARTICIPATION; FEMALE ADOLESCENTS
Abstract: Purpose: To estimate the global lifetime prevalence rate of anabolic-androgenic steroid (AAS) use and investigate moderators of the prevalence rate. Methods: A meta-analysis and meta-regression analysis was performed using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, and Google Scholar among others. Included were 187 studies that provided original data on 271 lifetime prevalence rates. Studies were coded for publication year, region, sample type, age range, sample size, assessment method, and sampling method. Heterogeneity was assessed by the I-2 index and the Q-statistic. Random effect-size modeling was used. Subgroup comparisons were conducted using Bonferroni correction. Results: The global lifetime prevalence rate obtained was 3.3% (95% confidence interval [CI], 2.8-3.8; I-2 = 99.7, P < .001). The prevalence rate for males, 6.4% (95% CI, 5.3-7.7, I-2 = 99.2, P < .001), was significantly higher (Q(bet) = 100.1, P < .001) than the rate for females, 1.6% (95% CI, 1.3-1.9, I-2 = 96.8, P < .001). Sample type (athletes), assessment method (interviews only and interviews and questionnaires), sampling method, and male sample percentage were significant predictors of AAS use prevalence. There was no indication of publication bias. Conclusion: Nonmedical MS use is a serious widespread public health problem. (C) 2014 Elsevier Inc. All rights reserved.
Cate of OECD: Health sciences
Year of Publication: 2014
Business Area: other
Detail Business: medicine & science
Country: USA
Study Area:
Name of Journal: ANNALS OF EPIDEMIOLOGY
Language: English
Country of Authors: [Sagoe, Dominic; Andreassen, Cecilie S.; Torsheim, Torbjorn; Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, N-5015 Bergen, Norway; [Molde, Helge] Univ Bergen, Dept Clin Psychol, N-5015 Bergen, Norway; [Andreassen, Cecilie S.] Bergen Clin Fdn, Competence Ctr, Bergen, Norway
Press Adress: Sagoe, D (reprint author), Univ Bergen, Dept Psychosocial Sci, Christiesgate 12, N-5015 Bergen, Norway.
Email Address: Dominic.Sagoe@psysp.uib.no
Citaion:
Funding:
Lists of Citation: Abrahin OSC, 2013, REV BRAS MED ESPORTE, V19, P27, DOI 10.1590/S1517-86922013000100005; Acevedo P, 2011, W INDIAN MED J, V60, P531; Adhikari P, 2000, NAT DRUG STRTAT HOUS, V6; ADLAF EM, 1992, J ALCOHOL DRUG EDUC, V38, P43; Adlaf EM, 2004, CANDIAN ADDICTION SU; Afolayan J, 2012, IOSR J APPL CHEM, V1, P31; Agathangelou S, 2010, ANABOLIC STEROIDS US; Al-Falasi O, 2008, OPEN SPORTS MED J, V2, P75; Ama PFM, 2003, BRIT J SPORT MED, V37, P307, DOI 10.1136/bjsm.37.4.307; ANDERSON WA, 1991, PHYSICIAN SPORTSMED, V19, P91; Andersson B., 2007, ALCOHOL DRUG USE AMO; Andrade Arthur Guerra de, 2012, Rev Bras Psiquiatr, V34, P294; Angoorani H, 2012, ARCH MED SCI, V8, P362, DOI 10.5114/aoms.2012.28566; Anton AJM, 2011, AFR J PHARM PHARMACO, V5, P654; Australian Institute of Health and Welfare, 2002, NAT DRUG STRAT HOUS, V11; Australian Institute of Health and Welfare, 2005, NAT DRUG STRAT HOUS, V13; Australian Institute of Health and Welfare, 2011, NAT DRUG STRAT HOUS, V25; Bachman J. G., 2012, COLL STUDENTS ADULTS, VII, P19; Bahrke MS, 2004, CURR OPIN PHARMACOL, V4, P614, DOI 10.1016/j.coph.2004.05.006; Baker JS, 2008, OPEN SPORTS MED J, V2, P38, DOI 10.2174/1874387000802010038; Baumert PW, 1998, J ADOLESCENT HEALTH, V22, P460, DOI 10.1016/S1054-139X(97)00242-5; BEAUVAIS F, 1992, AM INDIAN ALASKA NAT, V5, P13; Beaver KM, 2008, AM J PUBLIC HEALTH, V98, P2185, DOI 10.2105/AJPH.2008.137018; Berning JM, 2008, J AM COLL HEALTH, V56, P499, DOI 10.3200/JACH.56.5.499-504; BLOUIN AG, 1995, INT J EAT DISORDER, V18, P159, DOI 10.1002/1098-108X(199509)18:2<159::AID-EAT2260180208>3.0.CO;2-3; Bojsen-Moller J, 2010, SCAND J MED SCI SPOR, V20, P861, DOI 10.1111/j.1600-0838.2009.01023.x; Bolding G, 2002, ADDICTION, V97, P195, DOI 10.1046/j.1360-0443.2002.00031.x; Borenstein M., 2009, INTRO METAANALYSIS; Borenstein M., 2005, COMPREHENSIVE METAAN; Bosworth E, 1987, MED SCI SPORTS EX S3, V20, P17; Boyadjiev NP, 2000, J SPORT MED PHYS FIT, V40, P271; BROWER KJ, 1994, J PSYCHIAT RES, V28, P369, DOI 10.1016/0022-3956(94)90019-1; BUCKLEY W E, 1988, Journal of the American Medical Association, V260, P3441, DOI 10.1001/jama.260.23.3441; Cafri G, 2006, J CLIN CHILD ADOLESC, V35, P283, DOI 10.1207/s15374424jccp3502_12; Calabria B, 2009, 14 U NSW ALC RES CTR; Congress OHF, 1990, STEROID TRAFFICKING; Corbin CB, 1994, PEDIATR EXERCI SCI, V6, P224; Corder BW, 1975, ARIZ J HLTH PHYS ED, V18, P10; Cormack S, 1998, 57 NDARC U NEW S WAL; Deluliis D, 2012, J SPORT ADM SUPERVIS, V4, P3; De Micheli D, 2004, ADDICTION, V99, P570, DOI 10.1111/j.1360-0443.2004.00671.x; Dezelsky T, 1985, B NARCOTICS, V27, P49; Dodge T, 2011, DRUG ALCOHOL DEPEN, V114, P100, DOI 10.1016/j.drugalcdep.2010.11.011; Dodge TL, 2006, J ADOLESCENT HEALTH, V39, P367, DOI 10.1016/j.jadohealth.2005.12.025; Duchaine D., 1983, UNDERGROUND STERIOD; Duchaine D., 1981, ORIGINAL UNDERGROUND; Dunn M, 2011, J SCI MED SPORT, V14, P10, DOI 10.1016/j.jsams.2010.05.004; Dunn M, 2010, AUST NZ J PUBL HEAL, V34, P531, DOI 10.1111/j.1753-6405.2010.00603.x; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; DURANT RH, 1995, PEDIATRICS, V96, P23; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Elliot DL, 2007, ARCH PEDIAT ADOL MED, V161, P572, DOI 10.1001/archpedi.161.6.572; Elliot DL, 2004, ARCH PEDIAT ADOL MED, V158, P1043, DOI 10.1001/archpedi.158.11.1043; Ferenchick GS, 1996, J GEN INTERN MED, V11, P554, DOI 10.1007/BF02599607; Field AE, 2005, PEDIATRICS, V116, pE214, DOI 10.1542/peds.2004-2022; Field AE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e36; Fisher M, 1996, J ADOLESCENT HEALTH, V18, P329, DOI 10.1016/1054-139X(95)00067-3; FRANKLE MA, 1984, JAMA-J AM MED ASSOC, V252, P482; Gaa GL, 1994, J ATHL TRAINING, V29, P21; Gaa Gregory L., 1994, Journal of Athletic Training, V29, P216; Garevik N, 2010, DRUG ALCOHOL DEPEN, V109, P144, DOI 10.1016/j.drugalcdep.2009.12.024; Gmel G, 2007, J STUD ALCOHOL DRUGS, V68, P303; Goldfield Gary S, 2009, Eat Disord, V17, P200, DOI 10.1080/10640260902848485; Goltsos K, 2012, AFR J PHARM PHARMACO, V6, P66, DOI 10.5897/AJPP11.772; Grace FM, 2001, J SUBST USE, V6, P189, DOI 10.1080/14659890152558804; Gradidge P, 2011, ARCH EXERCI HLTH DIS, V2, P114; Gridley D, 1994, SPORT HLTH, V12, P11; Gruber AJ, 2000, PSYCHOTHER PSYCHOSOM, V69, P19, DOI 10.1159/000012362; Habeeb MB, 2012, AM J MENS HEALTH, V6, P462, DOI 10.1177/1557988312446508; Hakansson A, 2012, EUR ADDICT RES, V18, P83, DOI 10.1159/000333037; Handelsman DJ, 1997, INT J ANDROL, V20, P159, DOI 10.1046/j.1365-2605.1997.d01-285.x; Hando J, 1998, 56 NAT DRUG ALC RES; Hando J, 1997, NATL DRUG ALCOHOL RE, V31; Hibell B., 2012, 2011 ESPAD REPORT SU; Hibell B, 2000, 1999 ESPAD REPORT AL; Hibell B, 2004, ESPAD REPORT 2003 AL; Hibell B, 2007, 2007 ESPAD REPORT SU; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffman JR, 2007, MED SCI SPORTS EXERC, V40, P15; Hoffman JR, 2006, J SPORT SCI MED, V5, P182; Hope VD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003207; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; Ip EJ, 2012, PHARMACOTHERAPY, V32, P910, DOI 10.1002/j.1875-9114.2012.01123; Irving LM, 2002, J ADOLESCENT HEALTH, V30, P243, DOI 10.1016/S1054-139X(01)00414-1; Jalilian Farzad, 2011, Health Promot Perspect, V1, P32, DOI 10.5681/hpp.2011.002; JOHNSON MD, 1989, PEDIATRICS, V83, P921; Johnston LD, 2013, MONITORING FUTURE NA, VI; Kanayama G, 2001, PSYCHOTHER PSYCHOSOM, V70, P137, DOI 10.1159/000056238; Kanayama G, 2008, DRUG ALCOHOL DEPEN, V98, P1, DOI 10.1016/j.drugalcdep.2008.05.004; Kanayama G, 2012, PSYCHOTHER PSYCHOSOM, V81, P73, DOI 10.1159/000330415; Kanayama G, 2010, HORM BEHAV, V58, P111, DOI 10.1016/j.yhbeh.2009.09.006; Kanayama G, 2007, DRUG ALCOHOL DEPEN, V88, P156, DOI 10.1016/j.drugalcdep.2006.10.013; Kanayama G, 2003, DRUG ALCOHOL DEPEN, V71, P77, DOI 10.1016/S0376-8716(03)00069-3; Kanayama G, 2009, AM J PSYCHIAT, V166, P642, DOI 10.1176/appi.ajp.2009.08111699; Keene J, 1997, ADDICT RES, V4, P343, DOI 10.3109/16066359709002968; Kersey Robert D., 1996, Journal of Athletic Training, V31, P237; Kindlundh AMS, 1998, SCAND J SOC MED, V26, P71, DOI 10.1177/14034948980260010201; Kirwan A, 2012, VICTORIAN DRUG TREND; Klotz F, 2010, COMPR PSYCHIAT, V51, P312, DOI 10.1016/j.comppsych.2009.05.007; Kokkevi A, 2008, SUBST USE MISUSE, V43, P2053, DOI 10.1080/10826080802279342; KOMOROSKI EM, 1992, AM J DIS CHILD, V146, P823; Korkia P, 1997, INT J SPORTS MED, V18, P557, DOI 10.1055/s-2007-972681; Korte T, 1998, FORENSIC SCI INT, V97, P171, DOI 10.1016/S0379-0738(98)00159-5; KROWCHUK DP, 1989, AM J DIS CHILD, V143, P486; Kyselovicova O, 2008, FIT PERF J, V7, P65; Lambert MI, 1998, S AFR MED J, V88, P876; Laure P, 2004, INT J SPORTS MED, V25, P133; Laure P, 2007, BRIT J SPORT MED, V41, P660, DOI 10.1136/bjsm.2007.035733; Leifman H, 2011, INT J ENV RES PUB HE, V8, P2656, DOI 10.3390/ijerph8072656; Leit RA, 2002, INT J EAT DISORDER, V31, P334, DOI 10.1002/eat.10019; Letcher T, 1999, MONOGRAPH SERIES, V33; Lindqvist AS, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2012-091340; LINDSTROM M, 1990, J INTERN MED, V227, P407; Lippe J, 2008, YOUTH RISK BEHAV SUR; Lippe Jaclynn, 2008, Morbidity and Mortality Weekly Report, V57, P28; Lipsey MW, 2001, PRACTICAL METAANALYS; Ljungqvist A, 1975, Br J Sports Med, V9, P82; Lood Y, 2012, FORENSIC SCI INT, V219, P199, DOI 10.1016/j.forsciint.2012.01.004; Lorang M, 2011, J CHILD ADOLES SUBST, V20, P358, DOI 10.1080/1067828X.2011.598842; Luetkemeier MJ, 1995, J HLTH ED, V26, P4; Lundholm L, 2013, DRUG ALCOHOL DEPEN, V129, P110, DOI 10.1016/j.drugalcdep.2012.09.019; Lundholm L, 2010, DRUG ALCOHOL DEPEN, V111, P222, DOI 10.1016/j.drugalcdep.2010.04.020; MacNeil P, 1997, CANADAS ALCOHOL OTHE; Maharaj VR, 2000, W INDIAN MED J, V49, P55; Makanjuola BA, 2007, NIGER J PSYCHIATRY, V5, P14; Makkai T, 1998, PATTERNS DRUG USE AU; MALONE DA, 1995, CLIN J SPORT MED, V5, P25, DOI 10.1097/00042752-199501000-00005; Mattila VM, 2010, EUR J PUBLIC HEALTH, V20, P306, DOI 10.1093/eurpub/ckp124; Mattila VM, 2010, SCAND J MED SCI SPOR, V20, P330, DOI 10.1111/j.1600-0838.2009.00953.x; McCabe SE, 2007, DRUG ALCOHOL DEPEN, V90, P243, DOI 10.1016/j.drugalcdep.2007.04.004; MCKILLOP G, 1987, SCOT MED J, V32, P39; Mcllwraith F, 2012, AUSTR DRUG TRENDS SE, V81; McVeigh J, 2003, INT J DRUG POLICY, V14, P399, DOI 10.1016/S0955-3959(03)00141-5; Melia P, 1996, CLIN J SPORT MED, V6, P9, DOI 10.1097/00042752-199601000-00004; MIDDLEMAN AB, 1995, PEDIATRICS, V96, P268; Miller KE, 2005, SUBST USE MISUSE, V40, P1637, DOI 10.1080/108226080500222727; Miller KE, 2002, SOCIOL PERSPECT, V45, P467, DOI 10.1525/sop.2002.45.4.467; Ministry of Health, 2010, 59 NAT DRUG ALC RES; Moher D, 2009, PLOS MED, V21, P6, DOI DOI 10.1371/J0URNAL.PMED.1000097; Molobe ID, 2012, INT J MED MED SCI, V2, P77; Monaghan LF, 2002, SOC SCI MED, V55, P695, DOI 10.1016/S0277-9536(01)00195-2; National Advisory Committee on Drugs Public Health Information and Research Branch, 2012, DRUG US IR NO IR DRU; Newman M, 1987, MICHIGAN CONSORTIUM; Nilsson S, 2005, SUBST USE MISUSE, V40, P1, DOI 10.1081/JA-200030485; NILSSON S., 1995, EUR J CLIN PHARMACOL, V1, P9; Nilsson S, 2001, EUR J PUBLIC HEALTH, V11, P195, DOI 10.1093/eurpub/11.2.195; Nilsson S, 2001, SCAND J PRIM HEALTH, V19, P181; Nokleby H, 2013, NORD STUD ALCOHOL DR, V30, P331, DOI 10.2478/nsad-2013-0025; Nutter J, 1997, J STRENGTH COND RES, V11, P35; OHAERI JU, 1993, HUM PSYCHOPHARM CLIN, V8, P429, DOI 10.1002/hup.470080609; Oshikoya K, 2006, WORLD J MED SCI, V1, P133; Ozdemir L, 2005, J SPORT SCI MED, V4, P248; Pagonis TA, 2006, EUR PSYCHIAT, V21, P551, DOI 10.1016/j.eurpsy.2005.09.001; Pallesen S, 2006, SUBST USE MISUSE, V41, P1705, DOI 10.1080/10826080601006367; Papadopoulos FC, 2006, EUR J EPIDEMIOL, V21, P307, DOI 10.1007/s10654-006-0018-6; Parkinson AB, 2006, MED SCI SPORT EXER, V38, P644, DOI 10.1249/01.mss.0000210194.56834.5d; Perry H M, 1992, Br J Sports Med, V26, P259; Perry PJ, 2005, CLIN J SPORT MED, V15, P326, DOI 10.1097/01.jsm.0000180872.22426.bb; Phillips B.BurnsL, 2012, 59 NAT DRUG ALC RES, V74; POPE HG, 1994, ARCH GEN PSYCHIAT, V51, P375; Pope HG, 2001, PSYCHOTHER PSYCHOSOM, V70, P189, DOI 10.1159/000056252; Pope HG, 1996, COMPR PSYCHIAT, V37, P322, DOI 10.1016/S0010-440X(96)90013-9; Pope HG, 2012, BIOL PSYCHIAT, V71, P254, DOI 10.1016/j.biopsych.2011.06.024; Pope HG, 2000, AM J PSYCHIAT, V157, P1297, DOI 10.1176/appi.ajp.157.8.1297; Pope Jr HG, 1988, PHYSICIAN SPORTSMED, V16, P4; Pope Jr HG, 1988, PHYSICIAN SPORTSMED, V16, P80; Pope Jr HG, 2012, DRUG ABUSE ADDICTION, P251; POPE HG, 1988, PHYSICIAN SPORTSMED, V16, P75; Posiadała D., 2010, Studies in Physical Culture and Tourism, V17, P261; Rachon D, 2006, SOZ PRAVENTIV MED, V51, P392, DOI 10.1007/s00038-006-6018-1; Radakovich J, 1993, J Am Board Fam Pract, V6, P341; Rocha-Silva L, 1996, ALCOHOL TOBACCO OTHE; Rumbold G, 1998, 59 NAT DRUG ALC RES; Rysavy P, 2011, AUSTR DRUG TRENDS SE, V80; Sagoe D, KNOWLEDGE A IN PRESS; Sagoe D, PREVALENCE IN PRESS; Santos AM, 2011, SUBST USE MISUSE, V46, P742, DOI 10.3109/10826084.2010.534123; Sas-Nowosielski K, 2006, BIOL SPORT, V23, P225; SCHWELLNUS MP, 1992, S AFR MED J, V82, P154; Scott DM, 1996, AM J HEALTH-SYST PH, V53, P2068; Scottish Government, 2012, 2010 11 SCOTT CRIM J; Sepehri G, 2010, ADDICT HLTH, V1, P25; SFS, 1991, 19911969 SFS; Singhammer J, 2013, SPORT SCI REV, V22, P109; Smith K, 2011, DRUG MISUES DECLARED, V12/11; Solberg S, 1982, Br J Sports Med, V16, P169; Stafford J, 2013, AUSTR DRUG TRENDS SE, V91; Stafford J, 2011, AUSTR DRUG TRENDS SE, V55; Stilger VG, 1999, J COMMUN HEALTH, V24, P131, DOI 10.1023/A:1018706424556; Street C, 2000, J STRENGTH COND RES, V14, P289; Striegel H, 2006, DRUG ALCOHOL DEPEN, V81, P11, DOI 10.1016/j.drugalcdep.2005.05.013; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Substance Abuse and Mental Health Services Administration (SAMHSA), 1996, NAT HOUS SURV DURG A; Sutherland R, 2012, AUSTR DRUG TRENDS SE, V78; Tahtamouni LH, 2008, EUR J PUBLIC HEALTH, V18, P661, DOI 10.1093/eurpub/ckn062; TANNER SM, 1995, CLIN J SPORT MED, V5, P108, DOI 10.1097/00042752-199504000-00007; TAYLOR W N, 1987, Annals of Sports Medicine, V3, P155; TERNEY R, 1990, AM J DIS CHILD, V144, P99; Thorlindsson T, 2010, SUBST ABUSE TREAT PR, V5, P1; Topp L, 2001, MONOGRAPH NATL DRUG, V47; TRICKER R, 1989, J DRUG EDUC, V19, P313, DOI 10.2190/EGT5-4YWD-QX15-FLKK; Urhausen A, 2004, HEART, V90, P496, DOI 10.1136/hrt.2003.015719; van den Berg P, 2007, PEDIATRICS, V119, P476, DOI 10.1542/peds.2006-2529; Viera AJ, 2005, FAM MED, V37, P360; White V, 2009, AUSTR SECONDARY SCH; White V., 2012, AUSTR SECONDARY SCH; White V., 2001, MONOGRAPH COMMONWEAL, V46; White V, 2006, MONOGRAPH AUSTR GOVT, V60; White V, 2004, MONOGRAPH AUSTR GOVT, V56; WHITEHEAD R, 1992, J FAM PRACTICE, V35, P401; Wichstrom L, 2001, J STUD ALCOHOL, V62, P5; Wichstrom L, 2006, MED SCI SPORT EXER, V38, P1578, DOI 10.1249/01.mss.0000227541.66540.2f; Wilkins Chris, 2008, N Z Med J, V121, P61; Williamson D J, 1993, Br J Sports Med, V27, P200; WINDSOR R, 1989, MED SCI SPORT EXER, V21, P494; Wright S, 2000, J Health Psychol, V5, P566, DOI 10.1177/135910530000500413; Wroble RR, 2002, SPORT J, V5, P1; Yang CFJ, 2005, AM J PSYCHIAT, V162, P263, DOI 10.1176/appi.ajp.162.2.263; Yang CFJ, 2009, SOC NEUROSCI, V4, P49, DOI 10.1080/17470910801942876; Yesalis CE, 1988, PHYSICIAN SPORTSMED, V16, P6; YESALIS CE, 1995, SPORTS MED, V19, P326, DOI 10.2165/00007256-199519050-00003; YESALIS CE, 1988, PHYSICIAN SPORTSMED, V16, P90; YESALIS CE, 1992, PSYCHIAT ANN, V22, P7; YESALIS CE, 1993, JAMA-J AM MED ASSOC, V270, P1217, DOI 10.1001/jama.270.10.1217; Yesalis CE, 1988, PHYSICIAN SPORTSMED, V16, P8; Yesalis CE, 1988, PHYSICIAN SPORTSMED, V6, P100; Young MM, 2011, CROSS CANADA REPORT
Number of Citaion: 227
Publication: ELSEVIER SCIENCE INC
City of Publication: NEW YORK
Address of Publication: 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
ISSN: 1047-2797
29-Character Source Abbreviation: ANN EPIDEMIOL
ISO Source Abbreviation: Ann. Epidemiol.
Volume: 24
Version: 5
Start of File: 383
End of File: 398
DOI: 10.1016/j.annepidem.2014.01.009
Number of Pages: 16
Web of Science Category: Public, Environmental & Occupational Health
Subject Category: Public, Environmental & Occupational Health
Document Delivery Number: AG9BB
Unique Article Identifier: WOS:000335712500009
- reply : 0
-
- list
-
- prev
- next